Asia-Pacific has seen the largest growth in cardiovascular trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
Impressive early results for Vertex’s potentially curative stem cell diabetes therapy
A cure for Type 1 diabetes has come one step closer as Vertex reports 90-day...
Robotics hiring levels in the clinical trial operations industry rose in August 2021
19.7% of the companies included in our analysis recruited for at least one robotics-related position.
Regulatory roundup: Novartis’s breast cancer SERD tumbles after Phase I/Ib termination
Johnson & Johnson’s RVS vaccine and Enanta’s revised plans in NASH are among other assets reviewed by GlobalData’s Investigative News team.
Sagimet embraces AI-driven pathology for more consistent NASH analysis
In NASH trials, classifying patients between different fibrosis stages can be tricky due to pathologist bias.
Latest Deals
-
Elligo Health ResearchMergers & Acquisitions $135M
-
Reify HealthCapital Raising $220M
-
CertaraMergers & Acquisitions $310M
-
ParexelMergers & Acquisitions $8.5BN
-
Elligo Health ResearchMergers & Acquisitions $135M
-
Reify HealthCapital Raising $220M
-
CertaraMergers & Acquisitions $310M
-
ParexelMergers & Acquisitions $8.5BN
Weekly chart
Top countries for Environmental, Social, and Governance Jobs, June-August 2021
Source: GlobalData
| Country | Number of jobs |
|---|---|
| United States | 6607 |
| United Kingdom | 911 |
| India | 782 |
| China | 569 |
| Canada | 494 |
| Ireland | 328 |
| France | 291 |
| Switzerland | 211 |
| Germany | 196 |
| Belgium | 154 |
Latest News
Lilly’s tirzepatide reduces body weight in Phase III type 2 diabetes trial
The investigational therapy’s overall safety profile was consistent with the safety data measured at 52 weeks.
Enzychem’s EC-18 reduces occurrence of oral mucositis in Phase II trial
The therapy met the primary and secondary endpoints in the trial in chemoradiation-induced oral mucositis patients.
Inhibikase doses first subject in Phase Ib Parkinson’s treatment trial
The trial will evaluate the safety, pharmacokinetics and tolerability of IkT-148009 in 24 Parkinson’s patients.
Atea’s AT-527 fails to meet primary goal of Phase II Covid-19 trial
In the trial, the oral antiviral was demonstrated to be safe and well-tolerated with data in line with prior studies.
Latest Themes
Joe Biden’s global corporation tax deal: A prediction on what’s next
Why have the nations of the world agreed to a new minimum corporation tax rate? And what happens to so-called "Google taxes" now?
Cloud hiring levels in the clinical trial operations industry rose to a year-high in August 2021
45.1% of the companies included in our analysis recruited for at least one cloud-related position.
AI is coming — and you can take that to the bank
AI can leverage banks' biggest asset: data, which many a startup would die for. This can save waning banks and provide new income sources.
Remote communities of healthcare professionals are enabling DCTs
Hawthorne Effect’s Hero network is enabling continuous data capture in remote and hard to reach communities.
pHOXBIO eyes UK study of preventive Covid-19 nasal spray by year’s end
The nasal spray is designed to offer hours of protection from a SARS-CoV-2 infection.
Uneven Covid-19 vaccine efficacy in blood cancers mean masks to stay
A quarter of haematological cancer patients do not mount an effective immune response after Covid-19 vaccination.
Pacific Cancer Care to use Deep Lens’ AI solutions for clinical trials
Deep Lens’ VIPER solution can aid in automating the selection of eligible subjects during diagnosis and match them to trials.
Artificial intelligence hiring levels in the clinical trial operations industry rose in August 2021
24.9% of the companies included in our analysis recruited for at least one AI-related position.
Expert Commentary & Analysis
View MoreCompetition grows to be the next disease-modifying therapy for Alzheimer’s disease
There is a number of DMT therapies for AD that are at the last stages...
Enhertu set to become a blockbuster drug after outperforming Kadcyla
Enhertu’s drug antibody ratio and bystander effect make it a promising drug for cancers with...
Allogeneic CAR-T trials paused due to chromosomal abnormality detected in patient
Allogene Therapeutics’ stocks fell by 46% after the CAR-T trials were put on hold, though...
Rural China study finds salt substitute cuts risk of stroke
If public health guidelines in China prescribed a reduction in salt intake, this could lead...